Literature DB >> 8282350

Effect of lisinopril and metoprolol on arterial distensibility.

M Barenbrock1, C Spieker, A P Hoeks, W Zidek, K H Rahn.   

Abstract

Apart from lowering blood pressure, antihypertensive drugs may influence vessel wall function. In a randomized double-blind study, the effect of lisinopril and metoprolol on arterial distensibility was studied in 40 patients with essential hypertension. After a placebo run-in period, the patients were randomly treated with metoprolol (50, 100, or 200 mg) or lisinopril (5, 10, or 20 mg) for 10 weeks. In the lisinopril group, blood pressure decreased after 10 weeks of therapy from 173 +/- 10/102 +/- 5 to 155 +/- 10/85 +/- 3 mm Hg and in the metoprolol group from 167 +/- 12/102 +/- 4 to 153 +/- 8/84 +/- 3 mm Hg. Diameter (millimeters), relative change in diameter (percent), and distensibility (10(-3)/kPa) of the left common carotid artery were determined after the placebo run-in period and after 6 and 10 weeks of antihypertensive therapy. A multigate Doppler system was used to measure the vessel wall movements by Doppler analysis in M-mode; blood pressure was recorded by finger plethysmography (Finapres). Neither lisinopril nor metoprolol influenced the end-diastolic diameter of the common carotid artery after 6 and 10 weeks of treatment. In the lisinopril group, a significant increase of percent change in diameter (P < .05 compared with the baseline value; P < .05 compared with the metoprolol group) and distensibility (P < .01 compared with the baseline value; P < .05 compared with the metoprolol group) was observed. The results show that lisinopril but not metoprolol improves arterial distensibility in essential hypertension. Pressure-independent effects of angiotensin converting enzyme inhibitors may be important modulators of adaptive changes in the arterial wall.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282350     DOI: 10.1161/01.hyp.23.1_suppl.i161

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

1.  Effect of olprinone, a phosphodiesterase III inhibitor, on arterial wall distensibility: differentiation between aorta and common carotid artery.

Authors:  M Seki; K Mizushige; T Ueda; M Kitadai; H Matsuo
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Mechanical properties of normal and diseased cerebrovascular system.

Authors:  Ali P Ebrahimi
Journal:  J Vasc Interv Neurol       Date:  2009-04

3.  Progression of Carotid Arterial Stiffness With Treatment of Hypertension Over 10 Years: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Adam D Gepner; Yacob Tedla; Laura A Colangelo; Matthew C Tattersall; Claudia E Korcarz; Joel D Kaufman; Kiang Liu; Gregory L Burke; Steven Shea; Philip Greenland; James H Stein
Journal:  Hypertension       Date:  2016-11-14       Impact factor: 10.190

Review 4.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

5.  Trauma and Autonomic Dysregulation: Episodic-Versus Systemic-Negative Affect Underlying Cardiovascular Risk in Posttraumatic Stress Disorder.

Authors:  Paul A Dennis; Nathan A Kimbrel; Andrew Sherwood; Patrick S Calhoun; Lana L Watkins; Michelle F Dennis; Jean C Beckham
Journal:  Psychosom Med       Date:  2017-06       Impact factor: 4.312

6.  A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.

Authors:  Dalane W Kitzman; W Gregory Hundley; Peter H Brubaker; Timothy M Morgan; J Brian Moore; Kathryn P Stewart; William C Little
Journal:  Circ Heart Fail       Date:  2010-06-01       Impact factor: 8.790

7.  Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment.

Authors:  J Richard Jennings; Matthew F Muldoon; Julie Price; Israel C Christie; Carolyn C Meltzer
Journal:  Hypertension       Date:  2008-06-02       Impact factor: 10.190

Review 8.  Clinical impact of renin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. angiotensin receptor antagonists.

Authors:  Joseph L Izzo; Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

9.  From Brain to Behavior: Hypertension's Modulation of Cognition and Affect.

Authors:  J Richard Jennings; Alicia F Heim
Journal:  Int J Hypertens       Date:  2012-02-19       Impact factor: 2.420

10.  Should beta blockers be used in the treatment of hypertension in the elderly?

Authors:  L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.